Please Wait

Applying Filters...

Calcipotriol
USDMF
Table View

CDMO Activity Tracker: Veranova, Carbogen lead ADC investments; Axplora, Polfa Tarchomin, Famar expand European footprint

Data Compilation
#PharmaFlow

Pipeline Prospector June 2025: Sanofi, AbbVie, Eli Lilly, BioNTech lead pharma M&A spree; BMS, Astra ink major collaborations

Stock Recap
#PipelineProspector

Calcipotriol

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

49 API Suppliers, 20 USDMF, 11 CEP/COS, 1 EU WC, 1 KDMF, 15 NDC API, 22 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

17 Drugs in Development

17 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

113 FDF Dossiers, 23 FDA Orange Book, 55 Europe, 23 Canada, 7 South Africa, 5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.005%, SOLUTION;TOPICAL - 0.005% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, OINTMENT;TOPICAL - 0.064%;0.005%, SUSPENSION;TOPICAL - 0.064%;0.005%, AEROSOL, FOAM;TOPICAL - 0.005%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 DKSH, 4 Nanjing Well Pharmaceutical, 3 Actylis, 12 BASF, 1 Corel Pharma Chem, 2 Finar, 1 Pluviaendo, 1 Seppic, 1 Symrise, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

20 Topical, 7 Solubilizers, 6 Parenteral, 4 Film Formers & Plasticizers, 4 Emulsifying Agents, 4 Thickeners and Stabilizers, 3 Lubricants & Glidants, 2 Granulation, 2 Direct Compression, 1 Controlled & Modified Release, 1 Fillers, Diluents & Binders, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

29 News #PharmaBuzz

29 News #PharmaBuzz

GLOBAL SALES INFORMATION

12 US Medicaid Prescriptions, 54 Regulatory FDF Prices, 7 Annual Reports

MARKET PLACE

10 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

18 US Patents, 1 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 Others

$ Xls download

Filters

Log in to access your PharmaMiles and download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
29/07/2025	ChemExpress	China	SHANGHAI HAOYUAN CHEMEXPRESS CO LTD	29298	INTERMEDIATE OF CALCIPOTRIOL	2015-04-15	Active	II	N/A
29/07/2025	TAPI Technology & API Services	Israel	TAPI NL BV	16958	CALCIPOTRIENE USP	2003-11-14	Active	II	Complete	2012-11-30	2012-11-13

Contact us
to update this info

Calcipotriol

Calcipotriol

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

49 API Suppliers

20 USDMF

11 CEP/COS

1 EU WC

1 KDMF

15 NDC API

22 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

17 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

113 FDF Dossiers

23 FDA Orange Book

55 Europe

23 Canada

7 South Africa

5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.005%

SOLUTION;TOPICAL - 0.005% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

OINTMENT;TOPICAL - 0.064%;0.005%

SUSPENSION;TOPICAL - 0.064%;0.005%

AEROSOL, FOAM;TOPICAL - 0.005%

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 DKSH

4 Nanjing Well Pharmaceutical

3 Actylis

12 BASF

1 Corel Pharma Chem

2 Finar

1 Pluviaendo

1 Seppic

1 Symrise

1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

20 Topical

7 Solubilizers

6 Parenteral

4 Film Formers & Plasticizers

4 Emulsifying Agents

4 Thickeners and Stabilizers

3 Lubricants & Glidants

2 Granulation

2 Direct Compression

1 Controlled & Modified Release

1 Fillers, Diluents & Binders

1 Surfactant & Foaming Agents

DIGITAL CONTENT

29 News #PharmaBuzz

GLOBAL SALES INFORMATION

12 US Medicaid Prescriptions

54 Regulatory FDF Prices

7 Annual Reports

MARKET PLACE

10 APIs

1 FDF Dossiers

PATENTS & EXCLUSIVITIES

18 US Patents

1 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM

1 Others

Filters

SOLUTION;TOPICAL - 0.005% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons